Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C

Journal of Biological Regulators and Homeostatic Agents

Volumn 17, Issue 2, 2003, Pages 172-175

  Ferraro, Donatella ^a   Bonura, C ^a   Giglio, M ^a   Di Stefano, R ^a   Almasio, P L ^a   Di Marco, V ^a   Craxi, A ^a   Cacciola, I ^b   Squadrito, G ^b   Raimondo, G ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Chronic hepatitis C; Occult HBV infection; Pegylated interferon ; Treatment response; Viral dynamics

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; INTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION;

DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS C VIRUS; RNA VIRUSES;

EID: 12444280662     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fattovich G, Tagger A, Brollo L, et al. Hepatitis virus infection in chronic hepatitis B virus carriers. J Infect Dis 1991; 163: 400-2.
2. Pontisso P, Ruvoletto M G, Fattovich G, et al. Clinical and virological profiles in patients with multiple hepatitis infections. Gastroenterology 1993; 105: 1529-33.
3. Sato S, Shigetoshi F, Tanaka M, et al. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994; 21: 159-66.
4. Ohkawa K, Hayashi N, Yuki N, et al. Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol 1994; 21: 509-14.
5. Crespo J, Lozano J L, de la Cruz F, et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 1994; 89: 1147-51.
6. Ohkawa K, Hayashi N, Yuki N, et al. Long-term follow up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses. J Med Virol 1995; 46: 258-64.
7. Villari D, Pernice M, Spinella S, et al. Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study. Am J Gastroenterol 1995; 90: 955-8.
8. Alberti A, Pontisso P, Chemello L, et al. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol 1995; 22 (Suppl. 1): 38-41.
9. Zarski JP, Bohn B, Bastie A, et al. Characteristic of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998; 28: 27-33.
10. Cacciola I, Pollicino T, Squadrito G, et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341: 22-6.
11. Squadrito G, Orlando ME, Pollicino T, et al. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. Am J Gastroenterol 2002; 97: 1518-23.
12. Shih CM, Lo SJ , Miyamura T, Chien SY, et al. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993; 67: 5823-32.
13. Shih CM, Chen CM, Chien SY, et al. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol 1995; 69: 1160-71.
14. Weltman MD, Brotodihardjo A, Crewe EB, et al. Coinfection with hepatitis B and C or B,C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat 1995; 2: 39-45.
15. Shiratori Y, Shiina S, Zhang PY, et al. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer 1997; 80: 2060-7.
16. Mazzella G, Saracco G, Festi D, et al. Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial. Am J Gastoenterol 1999; 94: 2246-50.
17. Chiaramonte M, Stroffolini T, Vian A, et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999; 85: 2132-7.
18. Zignego AL, Fontana R, Puliti S, et al. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon treated patients with hepatitis C virus chronic hepatitis. J Med Virol 1997; 51: 313-8.
19. Torbensen M, Thomas DL. Occult hepatitis B. Lancet Inf Dis 2002; 2: 479-86.
20. Brechot C, Thiers V, Kremsdorf D, et al. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant o purely "occult"? Hepatology 2001; 34: 194-206.
21. Neumann AU, Lam NP, Dahari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of IFN-α therapy. Science 1998; 282: 103-7.
22. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-65.
23. Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-82.